Some of the earliest warning signs of breast cancer risk may be hidden deep within the molecular makeup of breast tissue—long before anything appears on a scan. To uncover those signals, researchers at MUSC Hollings Cancer ...
Apr 22, 2026
0
6
When patients start getting treated for conditions like psoriatic arthritis, or connective tissue diseases like lupus and systemic sclerosis, their heightened risk of cancer gradually decreases, according to a new five-year ...
Mar 31, 2026
0
6
Colon cancer is the third most prevalent form of cancer in the U.S., and its incidence is increasing among younger adults, particularly those younger than 50. While colon cancer screening has helped prevent and detect it ...
Mar 28, 2026
0
6
Many people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of treatment: an antibody designed to wipe out cancerous B cells plus a combination of four chemotherapy ...
Mar 25, 2026
0
6
Researchers at Baylor College of Medicine and collaborating institutions have developed a method that reveals the cellular makeup of tissues that support metastatic cancer growth, which is the primary cause of death for most ...
Apr 28, 2026
0
6
The stiffness of tumor tissue plays a role in how cancer spreads. Furthermore, stiff tumor tissue leaves traces in the affected cells, according to two recent research studies from Lund University. "This helps us to better ...
Apr 26, 2026
0
6
In a study published in NEJM Catalyst, Mayo Clinic researchers demonstrate that chemotherapy can be safely delivered in patients' homes. The study evaluated Mayo Clinic's Cancer CARE Beyond Walls (Connected Access and Remote ...
Mar 20, 2026
0
6
Cancer treatments can take a toll on a person's body. A patient's treatment may cause nausea, changes in appetite, taste and smell, diarrhea, or constipation, making it harder to meet their nutritional needs. Fortunately, ...
Apr 19, 2026
0
6
For patients with advanced solid tumors harboring specific genetic alterations, the first-in-class synthetic lethal combination of WEE1 inhibitor zedoresertib plus PKMYT1 inhibitor lunresertib demonstrated promising antitumor ...
Apr 20, 2026
0
6
A research team affiliated with UNIST has made a significant discovery explaining why liver cancers associated with obesity and metabolic disorders tend to be more aggressive and less responsive to conventional treatments. ...
Mar 18, 2026
0
6
